Convergence and reorientation via open innovation: The emergence of nutraceuticals

Frank Siedlok*, Palie Smart, Abhishek Gupta

*Corresponding author for this work

Research output: Contribution to journalArticle (Academic Journal)peer-review

22 Citations (Scopus)

Abstract

The use of networked organisational arrangements to conduct exchanges is one of the most distinctive features of high-tech research-intensive industries. Advances in biotechnology and genomics research have enabled a generic technology platform that has fuelled a more 'open' approach to innovation and learning. This relies on collaborations between networked partners and allows for the convergence and reorientation of traditional sectors. This paper lends support to the view that some technologies can trigger a higher system level innovation, that is, in addition to the inter-firm level, an inter-industrial and inter-institutional level convergence and re-orientation process. This paper explores how this phenomenon is being witnessed in the pharmaceutical and food sectors and fast becoming a dominant logic in the emerging nutraceuticals industry.

Original languageEnglish
Pages (from-to)571-592
Number of pages22
JournalTechnology Analysis and Strategic Management
Volume22
Issue number5
DOIs
Publication statusPublished - Jul 2010

Keywords

  • Innovation strategy
  • Knowledge management
  • New product development
  • Pharmaceutical industry
  • Technology and innovation studies
  • Technology management

Fingerprint Dive into the research topics of 'Convergence and reorientation via open innovation: The emergence of nutraceuticals'. Together they form a unique fingerprint.

Cite this